Coya Therapeutics, Correlations

COYA Stock

6.55 0.10 1.50%

The current 90-days correlation between Coya Therapeutics, Common and Cue Biopharma is 0.16 (i.e., Average diversification). The correlation of Coya Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Coya Therapeutics, Correlation With Market

Average diversification

The correlation between Coya Therapeutics, Common and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coya Therapeutics, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Moving together with Coya Stock

0.7	PLX	Protalix Biotherapeutics	Pair Corr
0.74	LUCD	Lucid Diagnostics	Pair Corr
0.79	WM	Waste Management	Pair Corr
0.73	GE	GE Aerospace	Pair Corr
0.64	CSCO	Cisco Systems	Pair Corr
0.73	JNJ	Johnson Johnson	Pair Corr
0.69	MMM	3M Company	Pair Corr
0.76	T	ATT Inc Aggressive Push	Pair Corr
0.73	IBM	International Business	Pair Corr

Moving against Coya Stock

0.71	SCLX	Scilex Holding	Pair Corr
0.65	CDIOW	Cardio Diagnostics	Pair Corr
0.64	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.62	ASMB	Assembly Biosciences Earnings Call Today	Pair Corr
0.61	CDIO	Cardio Diagnostics	Pair Corr
0.49	OCEAW	Ocean Biomedical	Pair Corr
0.46	ELVN	Enliven Therapeutics Downward Rally	Pair Corr
0.42	CMND	Clearmind Medicine Common	Pair Corr
0.74	MSFT	Microsoft Aggressive Push	Pair Corr
0.66	MRK	Merck Company	Pair Corr
0.57	CAT	Caterpillar	Pair Corr
0.34	DIS	Walt Disney	Pair Corr

Related Correlations Analysis

	CUE	LTRN	FENC	ELYM	ABOS	INZY	TERN	DAWN	GRTX	CGTX
CUE		0.65	0.0	0.0	0.27	0.07	0.2	0.56	0.0	0.59	CUE
LTRN	0.65		0.42	0.0	-0.21	-0.44	-0.24	0.24	0.0	0.19	LTRN
FENC	0.0	0.42		0.0	-0.64	-0.49	-0.54	-0.34	0.0	-0.5	FENC
ELYM	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	ELYM
ABOS	0.27	-0.21	-0.64	0.0		0.84	0.94	0.78	0.0	0.79	ABOS
INZY	0.07	-0.44	-0.49	0.0	0.84		0.92	0.59	0.0	0.56	INZY
TERN	0.2	-0.24	-0.54	0.0	0.94	0.92		0.76	0.0	0.68	TERN
DAWN	0.56	0.24	-0.34	0.0	0.78	0.59	0.76		0.0	0.82	DAWN
GRTX	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	GRTX
CGTX	0.59	0.19	-0.5	0.0	0.79	0.56	0.68	0.82	0.0		CGTX
	CUE	LTRN	FENC	ELYM	ABOS	INZY	TERN	DAWN	GRTX	CGTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TERN	+ 0.94	ABOS
TERN	+ 0.92	INZY
INZY	+ 0.84	ABOS
CGTX	+ 0.82	DAWN
CGTX	+ 0.79	ABOS
DAWN	+ 0.78	ABOS

High negative correlations

ABOS	- 0.64	FENC
TERN	- 0.54	FENC
CGTX	- 0.5	FENC
INZY	- 0.49	FENC
INZY	- 0.44	LTRN
DAWN	- 0.34	FENC

Risk-Adjusted Indicators

There is a big difference between Coya Stock performing well and Coya Therapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Coya Therapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CUE	4.66	0.11	0.02	0.09	4.67	(6.27)	7.19	(8.57)	38.78
LTRN	4.47	0.36	0.07	0.53	4.79	(5.45)	12.03	(6.68)	44.50
FENC	2.06	0.11	0.04	0.08	2.92	(2.25)	4.75	(3.56)	16.33
ELYM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ABOS	3.07	(0.69)	0.00	(0.47)	0.00	0.00	6.57	(7.09)	19.77
INZY	4.12	(1.46)	0.00	2.24	0.00	0.00	6.82	(9.17)	36.29
TERN	3.11	(1.01)	0.00	(0.93)	0.00	0.00	5.03	(6.98)	19.13
DAWN	2.88	(0.56)	0.00	7.46	0.00	0.00	6.36	(6.67)	22.86
GRTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CGTX	4.65	0.21	0.04	0.11	4.27	(6.89)	9.09	(6.94)	39.60

Coya Therapeutics, Corporate Management

Arun Swaminathan	Chief Officer	Profile
Howard Berman	Executive Chair	Profile
Gregory MacMichael	Chief Officer	Profile
Aaron Thome	Head Platform	Profile
Michelle Frazier	Senior Affairs	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC